絞り込み

16643

広告

Pegvisomant (PEGV) treatment in acromegaly patients resistant to somatostatin analogues is less effective in the real life than in clinical trials. This is a multicenter, observational, retrospective, longitudinal study. The aim was to detect characteristics which improve long-term PEGV effectiveness.
PMID: 29080965 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード